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Abstract
Objective: Septic arthritis is a medical emergency with significant associated morbidity
and mortality that requires joint drainage in addition to antibiotic therapy. Closed-needle
aspiration and surgery (via arthrotomy or arthroscopy) are the standard approaches to
joint drainage, though little data exists regarding treatment outcomes with each approach.
We compared long-term outcomes for adult patients with septic arthritis of a native joint
based on whether they received a ‘medical’ or ‘surgical’ approach to joint drainage.
Methods: We retrospectively reviewed all chart records for patients diagnosed with
septic arthritis at the West Haven VA Medical Center between January 2006 and
December 2015. Treatment outcomes were recorded at one year post-diagnosis.
Results: Sixty-two patients were diagnosed with native joint septic arthritis during the
study period, 19 who were managed medically and 43 surgically. There was no
significant difference in demographic variables, risk factors, clinical presentation,
laboratory parameters, or duration of antibiotic therapy between the two groups. 81% of
medically-managed patients and 82% of surgically-managed patients achieved a full
recovery within 12 months. Overall mortality was 3.2%, and both patients who died
were managed surgically. There were no significant predictors of poor treatment
outcome aside from Black race.
Conclusion: Our findings suggest that medical management of septic arthritis with
closed-needle aspiration is non-inferior to surgical management in terms of both
morbidity and mortality. Given the small sample size, a prospective randomized control
trial is needed to guide definitive recommendations on the best form of joint drainage.
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I. Introduction
Septic arthritis has long been recognized as a medical emergency with significant
associated morbidity and mortality. Mortality estimates range from 4-13% in native joint
infections, with rates as high as 20% observed in prosthetic joints. [1-9] Of patients
surviving an episode of septic arthritis, roughly one-third experience functionally
impairing joint deterioration as a result. [2, 3, 5, 9] The incidence of septic arthritis is
estimated to be 4-12 per 100,000 person-years among the general population. [7, 9-12]
Several studies have shown particularly vulnerable populations, such as those with preexisting joint disease [13] and socioeconomically marginalized groups such as IV drug
users in Northern Europe [4] and the Aboriginal people of Australia [7], to have much
higher rates of infection. There is further evidence that the incidence of septic arthritis is
rising due to an increase in the number of iatrogenic infections [10, 12] and the
demographic reality of an ageing population. [14] Given its considerable associated
morbidity and mortality, any patient suspected of having an infected joint requires
immediate hospitalization for assessment, supportive care, and prompt treatment as
necessary. [15]
Morbidity associated with septic arthritis is typically due to irreversible joint damage
likely caused by a combination of bacterial virulence factors, the host inflammatory
response, and some measure of tissue ischemia. [16] Tarkowski’s work with model
murine systems of S. aureus septic arthritis has suggested that certain virulence factors
play a major role in promoting joint damage. [17] Further work by his group has
highlighted the importance of the host immune response. They have identified TNFalpha, IL-1, and IL-10 as potential protective factors in mediating septic arthritis, while
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showing an association between increased IL-4 activity and higher incidence of and
mortality from septic arthritis. [18-21] Others have identified tissue ischemia as a third
potential mechanism of joint injury, related to the avascularity of cartilage and its
dependence on the diffusion of oxygen and nutrients from the synovium. Stevens et al
suggested that the accumulation of purulent exudate and the resulting increased
intraarticular pressure may eventually cause tamponade of synovial blood flow and
subsequent cartilage anoxia. [22]
The cumulative effect of these mechanisms is rapid destruction of the cartilage
extracellular matrix which, due to the poor regenerative capacity of adult articular
cartilage, can result in long-term joint dysfunction. In rabbit models, studies have
demonstrated a greater than 20% loss of proteoglycans from cartilage extracellular matrix
within 2 days of E. coli inoculation and nearly 40% loss of type II collagen within three
weeks. [23, 24] A 2003 study comparing the use of low-dose intravenous dexamethasone
therapy in conjunction with antibiotic therapy versus antibiotic therapy alone further
highlighted the importance of the host immune response as a mediator of joint damage.
This double blind, randomized, placebo-controlled trial in 123 children showed that the
addition of dexamethasone to conventional antimicrobial therapy reduced clinical
duration of septic arthritis and decreased the extent of joint damage and dysfunction. [25]
While similar studies have not been carried out in adults, the role of host immune system
in causing the long-term sequelae of septic arthritis is increasingly clear.
Given our understanding of the swift and destructive course of septic arthritis based
on its pathogenesis, prompt diagnosis and treatment are essential. [26] Septic arthritis
remains, however, a challenging diagnosis. In adults it continues to be ultimately a
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clinical determination, as the gold standard of culturing bacteria from an infected joint
can take days or may not be possible at all in the setting of prior antibiotic use. [27]
Newman identified three primary means of diagnosing septic arthritis: a) positive culture
from joint fluid or tissue, b) positive culture from another source (blood, urine, etc.) with
signs and symptoms of an infected joint, or c) no organism cultured anywhere but with
histologic or radiologic evidence of infection or turbid fluid aspirated from a joint in the
right clinical setting. [28] In one study of 242 instances of septic arthritis in a single UK
district over a 10-year period, the authors found that 70% of cases were associated with a
positive joint culture, 13% with a positive culture from another source, and 16% with
joint aspiration of sterile pus in the setting of prior antibiotic use. [9]
In considering the inherent delay of awaiting culture results and our understanding
that roughly one-third of joint cultures in patients with septic arthritis will be negative,
several researchers have assessed the capacity of different aspects of the patient history,
physical examination, and laboratory testing to contribute to the diagnosis or exclusion of
septic arthritis. A 1995 prospective observational study from a rheumatology clinic
evaluated risk factors for septic arthritis among 37 patients with septic arthritis as
compared to 4,870 patients without septic arthritis. In a multivariate analysis, the authors
found a significant association between several features of the history and physical exam
and a diagnosis of septic arthritis: age >79, history of diabetes mellitus, history of
rheumatoid arthritis, history of joint surgery, presence of hip or knee prosthesis, and the
presence of skin infection over the affected joint. [13] Goldenberg’s early study of
outcomes in septic arthritis noted the elevation of ESR in all but one of his cases,
suggesting the possibility of ESR having some discriminatory value in diagnosis. [3]
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More recent systematic reviews have called into question the diagnostic utility of
most traditional clinical, history, or laboratory findings in changing the pre-test
probability of septic arthritis. The 2007 systematic review by Margaretten et al examined
14 studies that included a total of 653 patients presenting with a potentially septic
peripheral monoarticular arthritis. [29] While the “classic” presentation of septic arthritis
is the febrile patient with a hot, swollen, erythematous, and painful joint, their review
found limited evidence to suggest that any clinical feature is significantly specific for
septic arthritis. They also concluded that neither the absence of a fever nor a normal
serum white cell count, ESR or CRP could reliably exclude the diagnosis of septic
arthritis. They did find, however, that higher white cell counts in the synovial fluid and
presence of more than 90% neutrophils in the synovial fluid increased the likelihood of
septic arthritis. For synovial white cell counts, the likelihood ratios were 0.32, 2.9, 7.7,
and 28.0 respectively for levels of <25,000/mm3, > 25,000/mm3, >50,000/mm3, and
>100,000/mm3. The likelihood ratio for neutrophils comprising >90% of synovial white
cell count was 3.4.
A similar 2011 review identified having a history of joint surgery [LR =6.9] and the
presence of a skin infection overlying a prosthetic joint [LR=15.0] as the only features
from the history and physical to significantly alter the pre-test probability for septic
arthritis. [30] The authors found that serum WBC, ESR, and CRP were not useful in the
acute diagnosis of joint infection. They did, however, affirm the diagnostic value of
synovial fluid white cell count, with likelihood ratios of 0.33, 1.06, 3.59 and infinity
respectively for levels of <25,000/mm3, 25-50,000/mm3, 50-100,000/mm3, and
>100,000/mm3. A 2016 study of 458 knee aspirates (with 22 confirmed as septic
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arthritis based on synovial fluid culture) largely supported the findings of the two review
mentioned. [31]

Their analysis indicated that patient baseline characteristics, a history

of fever, and serum lab parameters were not reliable predictors of septic arthritis. They
also concurred that synovial white cell count was a significant predictor of joint infection,
with the highest combined sensitivity and specificity coming at a level greater than
64,000 (40% sensitive, 90% specific; LR = 2.8). This study did not, however, find the
percentage of neutrophils in synovial white cell count to be a significant predictor of joint
infection.
Finally, several studies of septic arthritis have examined the value of x-ray, CT,
MRI, and bone scans in discriminating septic from other forms of acute arthritis. While
these radiologic studies have proven effective at identifying effusions, diagnosing
osteomyelitis, and assessing the presence and extent of inflammation and tissue damage,
they have been unable to distinguish between infective and other causes of acute
inflammatory arthritis. [14]
In summary, with few aspects of the history and physical exam meaningfully
contributing to the diagnosis or exclusion of septic arthritis, and with little help provided
by serum lab tests or radiography, clinicians are largely left to use their clinical judgment
and white cell counts from joint aspiration in order to make the timely diagnosis of joint
infection while awaiting culture results. At worst, when opting for a conservative
approach, clinicians may end up unnecessarily beginning empiric antibiotics in order to
potentially prevent rapid joint damage and severe functional deterioration.
Amidst such diagnostic uncertainty, professional societies have largely avoided
prescribing definitive recommendations for the diagnosis and management of the
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potential septic joint. While the IDSA has published guidelines for the diagnosis and
management of prosthetic joint infections [32] and is currently developing guidelines for
the management of joint infections in children, they have remained notably silent on how
to handle the infected native joint in adults. The UK took an initial step forward in 2006
with the release of their Guidelines for management of the hot swollen joint in adults,
jointly developed by the British Society for Rheumatology, British Orthopaedic
Association, and Royal College of General Practitioners. [15] In it, the authors lay out a
clear protocol for working up potential septic arthritis which includes mandatory
aspiration of synovial fluid for Gram stain, culture, cell count, and microscopy prior to
initiation of antibiotics. They highlight that blood cultures should be collected, as well as
laboratory assessment of ESR and CRP at baseline in order to monitor ongoing response
to treatment (not for diagnosis, notably). The guidelines reinforce that x-rays and MRI
are of no benefit in diagnosing septic arthritis, at the same time acknowledging that
radiographs may show chondrocalcinosis and that MRI is most sensitive in detecting
osteomyelitis if there is clinical suspicion.
On the issue of management, the UK guidelines become notably vaguer given the
paucity of clinical data upon which to guide treatment. They indicate that there is no
evidence upon which to advise optimal duration of IV or PO antibiotics, while noting the
traditional approach of 6 weeks duration. The guidelines make clear that “septic joints
should be aspirated to dryness as often as required” but make no recommendation as to
the relative effectiveness of closed-needle aspiration versus an arthroscopic surgical
approach, making an equivocal recommendation that leaves the choice up to the provider.
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Interestingly, the authors do note some special consideration for management of the
infected hip, stating that “urgent open debridement is often necessary.”
The question of how best to drain a septic joint is of paramount importance in
light of our understanding of the disease pathogenesis being a combination of bacterial
virulence, host inflammatory response, and tissues ischemia secondary to increased intraarticular pressure. Removal of pus from the closed joint space is essential for multiple
reasons: a) to increase the effectiveness of antibiotics and speed bacterial clearance, b) to
enable release of cytokines that contribute to joint destruction, and c) to decrease the
elevated intra-articular pressure. As noted in the UK guidelines, pus removal can be
accomplished by either serial closed-needle aspiration or by surgical drainage via
arthroscopy or open arthrotomy. Manadan et al, in their 2004 review of evidence
comparing the effectiveness of closed-needle aspiration versus surgical lavage, detailed
the practical advantages of each approach: “With surgical lavage, direct visualization
permits debridement and lysis of adhesions, and high-volume lavage of the joint is
possible; proponents of the surgical approach contend that lavage is necessary to
adequately remove purulent material from the infected joint and thus protect the articular
cartilage from rapid destruction. Conversely, surgical lavage is an invasive procedure,
exposes the patient to the risks of anesthesia, and is a one-time procedure that cannot
accommodate ongoing purulent synovial effusions. In contrast to surgical lavage, daily
arthrocentesis is noninvasive and can be performed repeatedly until the infection is
cleared.” [33] Manadan’s review ultimately concluded that, based upon the limited
available literature, outcomes of patients treated with daily arthrocentesis were at least
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comparable with surgical lavage. The authors were unable, however, to comment
regarding the superiority of either approach due to the limited data available.
The equivocal recommendation in the UK guidelines regarding the optimal
approach to joint drainage reflects the near total lack of outcomes data on the
management of septic arthritis in this regard. Only one study prior to Manadan’s 2004
review directly compared outcomes of daily arthrocentesis versus surgical lavage, and
only two additional such studies have been published since. In the original 1975
retrospective study by Goldenberg et al, the authors compared outcomes among 59
patients hospitalized for septic arthritis who presented over an 8-year period. For
inclusion in the study, patients had to present within 14 days of joint symptom onset and
have a positive synovial fluid culture. Cases of gonococcal arthritis were excluded, and
12 of the 59 patients were children. After consideration of polyarticular septic arthritis, a
total of 73 affected joints were included in the analysis. All patients received appropriate
antibiotics, with 55 joints managed via serial closed-needle aspiration and 18 via open
arthrotomy. Patients were followed via clinic records for a brief period, with 80% having
a follow-up period of at least three months. This study found that patients treated
medically with arthrocentesis had a higher rate of full recovery (67% vs. 42%), lower rate
of poor outcome (21% vs. 53%), and higher rate of death (12% vs 5%) than patients
treated surgically with open arthrotomy. The authors noted, however, that these
differences were not statistically significant, and they also noted that the increased
percentage of hip infections in the surgical group (22% vs. 2%) contributed to the
differential outcome because of the universally poorer outcomes associated with infected
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hip joints. With these caveats, the authors concluded that “needle drainage appeared in
general to be the preferable initial mode of treatment” of the septic joint. [3]
A second study directly comparing outcomes of medical versus surgical
management in septic joints did not come until 2009 when Ravindran et al retrospectively
analyzed outcomes from 50 adult patients hospitalized at a UK academic center over a 6year period. Of the 51 episodes of septic arthritis, 32 were managed medically with serial
arthrocentesis and 19 surgically with arthroscopy or arthrotomy. All episodes were
monoarticular and included only cases of native joints with a positive synovial fluid
culture. Patients were followed until time of discharge. As in the Goldenberg study, the
authors observed better outcomes among the medically managed group though again did
not reach the level of statistical significance. Among medically treated patients, 69%
achieved full recovery as compared to 53% of the surgically treated patients (p=0.24).
When comparing knee infections only, they observed 71% full recovery with medical
management (n=24) and 38% for surgical management (n=13) while nearly achieving
statistical significance (p=0.05). They did note a slightly increased length of stay for
patients treated medically (16.5 vs 15 days). Based on these findings, the authors
concluded that surgical treatment is not superior to medical treatment in draining pus as
part of septic joint management.[8]
A recent retrospective study from a university hospital in Spain analyzed data
from 186 hospitalized patients with septic arthritis over a 9-year period. The study
authors included only adults with native joint infections that had positive synovial fluid
cultures. Their analysis compared rates of treatment failure—defined as death, admission
to ICU, readmission for septic arthritis, or need for surgery after 72 hours of initial
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treatment—between patients managed with closed-needle aspiration (n = 154) versus
surgical drainage (n= 32). The authors found that the type of joint drainage appeared to
depend primarily on which service the patient was admitted to. Their analysis showed
that rates of treatment failure did not differ significantly between patients managed with
early surgery versus conservative management (53.1% vs 37.0%, p =0.09). They did
note, however, as in the Goldenberg study, that the surgical group had a higher
percentage of hip infections that were differentially associated with treatment failure. [34]
Other studies have analyzed joint drainage technique as a predictor of poor outcome
without directly comparing outcomes with medical versus surgical management. In
another UK study of 242 hospitalized patients with septic arthritis that included children
and prosthetic joints, multivariate analysis demonstrated an association between
arthroscopy and arthrotomy with increased morbidity (OR 1.72, 3.74 respectively) but
decreased mortality (OR 0.44, 0.16 respectively). The associations with arthrotomy
achieved statistical significance. Other factors that were positively and significantly
associated with increased morbidity included history of diabetes mellitus, age >65, and
infections with Streptococcus or other Gram-positive organisms aside from S. aureus. [9]
A 1996 study of 135 patients in the Northern Territory of Australia, which also included
children and prosthetic joints, found that surgical lavage as compared to closed-needle
aspiration was associated with lower rates of requiring a repeat procedure and shorter
length of stay. [7] Finally, a 1986 UK study of 74 cases of septic arthritis (including
children) concluded, without presenting any of the accompanying data, that there was no
difference in outcome with surgical drainage, noting that surgical drainage was actually
associated with higher rates of complications and permanent immobility. [1]
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Considered together, these studies directly and indirectly comparing the effectiveness
of medical versus surgical management of septic arthritis present an inconclusive picture
regarding how best to drain an infected joint. While all three studies that directly
compared outcomes showed better patient outcomes with closed-needle aspiration, all of
the studies were retrospective and none achieved statistical significance due to small
sample sizes. This lack of sufficient evidence to inform recommendations accounts for
the absence of clear management guidelines. Perhaps no observation speaks better to the
nature of this clinical “no-man’s land” than the incredible practice variation seen across
all of these small studies. It is obvious that practitioners are suffering from insufficient
evidence to inform their practice, as during the same time period only 17% of patients in
a Spanish academic center underwent surgical drainage [34] as compared to 94% in a
West Texas hospital. [6] A 2011 web-survey of rheumatologists (n=74) and orthopedic
surgeons (n=77) further reinforces this notion. While the authors were surprised to find
relative agreement between the two specialties in terms of how they believe drainage of a
septic joint should be performed (77% of rheumatologists and 66% of orthopedic
surgeons recommended surgical joint drainage), less than one quarter of each specialty
cited published guidance as their main evidence base in treating septic arthritis. [35]
In summary, septic arthritis is a medical emergency with significant associated
morbidity and mortality that must be diagnosed clinically while awaiting synovial fluid
cultures. Timely drainage of a septic joint is essential to improve antibiotic effectiveness,
enable release of cytokines destructive to articular cartilage, and decrease intra-articular
pressure that can hasten tissue ischemia and joint damage. Current guidelines
equivocally recommend use of either closed-needle aspiration or surgical drainage (via
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either arthroscopy or arthrotomy) to achieve pus removal. Existing data provides
insufficient evidence to indicate superiority of either the medical or surgical approach to
joint drainage, though limited retrospective studies suggest that medical management is at
least non-inferior. Given the severe functional deterioration and mortality associated
with poor treatment outcomes, more data is needed on outcomes of medical versus
surgical management of the septic joint in order to inform the development of definitive
treatment guidelines.

II. Statement of Purpose
The primary purpose of this research is to compare outcomes of patients with
septic arthritis at the West Haven VA Connecticut Medical Center, based on whether they
were managed medically with joint drainage via closed-needle aspiration or surgically
with joint drainage via arthroscopy or arthrotomy. Our hypothesis is that there will be no
significant difference in mortality or functional deterioration attributable to septic arthritis
between these groups at one year post-diagnosis. In addition, we intend to assess risk
factors that may be associated with poor outcomes for these patients.
Secondary aims of this study include description of the presentation and diagnosis
of septic arthritis within our unique setting. Specific questions to address include:
•

What clinical features and laboratory parameters are associated with the
diagnosis of septic arthritis?

•

On what basis are patients diagnosed with septic arthritis?

•

What joints are most commonly infected?
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•

What organisms most commonly cause septic arthritis?

We will also examine whether there are significant differences in presentation (clinical
features, joint involved, organism, etc.) between medically- and surgically-managed
patients in regards to the factors above that may help explain clinical decision-making as
to which joint drainage technique is employed. Our hypothesis is that there will be
significant differences in the presentation of medically- vs. surgically-managed patients.

III. Methods
Design and setting
This hospital-based retrospective chart review was conducted at the West Haven
VA Connecticut Medical Center (VACT; West Haven, CT). All episodes of septic
arthritis occurring among patients over a ten-year period (January 1, 2006 to December
31, 2015) were identified. By design, all patients at the West Haven VA are adults.
Patients with infection of a prosthetic joint were excluded from this study given that
guidelines for the diagnosis and management of prosthetic joint infections are already
well-established. Patients with implanted hardware overlying or adjacent to the infected
joint were also excluded as these few patients were uniformly treated with surgical
removal of the hardware and had distinct underlying risk factors for joint infection not
relevant to management a typical native joint infection. This study also excluded septic
arthritis associated with Lyme disease or gonococcal infection, as clear guidelines also
exist for management of these infections.
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This study was designed in accordance with the ethical standards of the VACT
Ethics Committee and approved by its Institutional Review Board. As a retrospective
study, patient care was not influenced as part of study execution. No written informed
consent to participation was necessary.
Case definition
All included cases met one of Newman’s diagnostic criteria for septic arthritis
[28]: (A) positive culture from an affected joint (synovial fluid or tissue), (B) positive
culture from another site in a patient with clinical features of septic arthritis, and (C)
negative cultures but clinical features and purulent joint fluid consistent with septic
arthritis in a patient having undergone prior antibiotic therapy. No cases were included
based on histologic or radiologic evidence of septic arthritis alone. All organisms were
isolated and identified by the West Haven VA microbiology laboratory utilizing
conventional biochemical assays.
Ascertainment
Two methods were used to retrospectively identify potential cases of septic
arthritis diagnosed between January 1, 2006 and December 31, 2015. First, an exhaustive
list of ICD codes related to septic arthritis, joint infection, arthrocentesis, arthroscopy and
arthrotomy for an infected joint, and pyogenic arthritis were used to search all hospital
records over this period. Second, a list of all positive synovial fluid cultures was
obtained from the microbiology laboratory as a cross-check to ensure that as many cases
as possible of septic arthritis were captured, given that it is a relatively uncommon
diagnosis.
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Data collection
For all potential cases of septic arthritis, all patient records from the course of
their admission or treatment were reviewed with data extracted on the joint location, joint
type (native vs. prosthetic), results of diagnostic joint aspirations (including culture, cell
counts, and microscopy), results of all other cultures done, and history of antibiotic use.
Based on this data and the clinical presentation as documented by the medical team, all
cases of native joint septic arthritis were identified. For all definite cases of septic
arthritis meeting inclusion criteria, a structured data extraction tool was used to review
records from the date of presentation to at least one year post-diagnosis. In addition to the
variables mentioned above, other items extracted included the following: race, gender,
history of diabetes mellitus, history of joint disease, history of joint surgery, HIV status,
history of IV drug use, use of immunosuppressive medications, factors precipitating
diagnosis, joint functional status prior to infection, involvement of other joints, presence
of fever/joint pain/swelling/erythema/limited range of motion, joint function at time of
presentation, serum WBC/ESR/CRP, number of times joint was aspirated, use of
antibiotics prior to diagnostic aspiration, type of surgical procedure (if done),
radiographic studies done, type and duration of antibiotics given, type of disposition,
joint function upon discharge and at follow-up visits up to one-year post-discharge, and
date/cause of death. If patients did not have a recorded follow-up visit between 9 to 12
months post-discharge, subsequent visits were reviewed until finding the next visit with
documentation of function of the affected joint.
Treatment and outcome coding
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All episodes of septic arthritis were coded as receiving ‘medical’ or ‘surgical’
management based on the method of joint drainage used over the course of their
treatment. Patients were classified as receiving ‘surgical’ management if they went to the
operating room for joint drainage at any point during their admission. ‘Surgical’ patients
were then further classified as being treated with either arthroscopy or arthrotomy based
on review of surgical notes. All other episodes were classified as receiving ‘medical’
management.
The number of closed-needle joint aspirations was counted to include only those
done prior to surgery for those who went to the operating room for surgical drainage. For
the few patients with multiple joints involved, our analysis only included treatment of the
joint of primary complaint.
As noted above, the medical records of all included patients were reviewed for at
least one year following the diagnosis of septic arthritis. Using a combination of notes
from providers in Medicine, Orthopedics, Rheumatology, Infectious Disease,
Kinesiotherapy, Physical Therapy, and Primary Care, specific documentation was made
regarding function of the affected joint at 1-2 months, 3-9 months, and 12 months postdiagnosis. Specific attention was paid to documentation of pain, swelling, range of
motion, and any changes in function from the patient’s baseline prior to infection. An
episode was recorded as ‘Full Recovery’ if the patient did not have any deterioration in
joint function from baseline at 12 months post-discharge. An episode was recorded as a
‘Poor Outcome’ if the patient met one of the following criteria at 12 months postdischarge: a) experienced any deterioration in joint function, b) failed to clear the
organism from the joint based on aspirations done post-treatment, c) experienced
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recurrent infection within the same joint within 12 months post-diagnosis after having a
documented culture-negative joint aspiration, d) treatment required full or partial
amputation, or e) the patient died as a result of their joint infection. If a patient did not
have any documented visits at 12 months post-diagnosis or beyond with no
documentation of death, they were classified as “Lost-to-follow-up” and therefore
excluded from the final outcomes analysis. Patients with a date of death documented in
the medical chart within 12 months post-discharge were recorded as such. Records were
thoroughly reviewed to determine if the cause of death could be reasonably attributed to
complications related to septic arthritis.
Statistical Analysis
All statistical analysis was performed using SAS software (version 9.4). All
analyses were stratified by type of management (‘medical’ versus ‘surgical’), with
aggregate findings for the entire sample also shown. Categorical variables are reported as
the frequency and percentage. Continuous variables are reported as the mean and
standard deviation with any missing variables noted. For comparison between the two
management groups, all tests were two-sided with a designated significance threshold of
p<0.05. For categorical variables, the two groups were compared using a Fisher’s exact
test. For continuous variables, the two groups were compared using either the Student’s
t-test or Mann-Whitney U-test.
A univariate logistic regression model was used to analyze risk factors associated
with a ‘Poor Outcome’ and those associated with ‘death attributable to septic arthritis’,
again for each treatment group and the sample overall. The following risk factors were
analyzed as part of this analysis: type of management, age > 65, age > 80, gender, race,
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joint location, infecting organism, use of immunosuppressive medications, history of
DM, HIV status, history of IVDU, history of joint disease or joint surgery, factors
precipitating infection, serum WBC and ESR at presentation, time from presentation to
operating room, duration of antibiotics, and type of disposition.
Attribution
All chart review and data collection was completed by the present author along
with Dr. Shaili Gupta and Dr. Juergen Holleck, both Assistant Professors at the Yale
School of Medicine. The data collection tool was designed and managed by the present
author. All final coding regarding treatment outcomes at 12 months post-discharge was
done by Dr. Shaili Gupta, who is also the adviser and Principle Investigator on this
project. All statistical analysis was completed by the present author.

IV. Results
Case ascertainment
A total of 366 distinct episodes of potential septic arthritis were identified over
the study period from an initial medical record search using ICD codes related to septic
arthritis. Subsequent search of positive synovial fluid cultures from the microbiology lab
incorporated an additional 85 unique cases. Of the total 451 potential episodes of septic
arthritis, 333 were excluded as cases of septic arthritis after thorough chart review. The
most common alternative diagnoses were crystal arthropathy, degenerative joint disease,
and septic bursitis. Of the 118 episodes confirmed to be septic arthritis, 48 were found to
involve prosthetic joints and therefore excluded from further analysis. Within the 70
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confirmed episodes of native joint septic arthritis, three cases of Lyme arthritis and five
cases involving overlying or adjacent implanted hardware were excluded. There were no
identified cases of gonococcal arthritis. The final sample, therefore, comprised 62 adult
patients with septic arthritis meeting inclusion criteria.
Management of joint drainage and antibiotic therapy
All but 2 of the 62 patients included in the study were hospitalized for at least one
night; the two non-hospitalized patients were managed medically as outpatients. Attempts
to aspirate the affected joint were made in all but 2 of the 62 cases of septic arthritis. The
two non-aspirated joints were both small and deemed to require surgical intervention
regardless of the aspiration findings based upon the clinical picture and patient history.
Intraoperative cultures confirmed the diagnosis of septic arthritis in both cases.
Forty-three of the 62 patients (69%) were managed surgically, with the remaining
19 cases managed conservatively with antibiotics and closed-needle aspiration alone. Of
the surgically-managed patients, arthroscopy was the employed method of joint drainage
in 18 cases (42% of all surgical cases) with the remaining 25 drained via open
arthrotomy. Medically-managed patients had the affected joint aspirated, on average,
2.42 times over the course of their treatment, while surgically-managed patients had an
average of 2.44 joint aspirations done prior to having the joint surgically drained in the
operating room. On average, surgically-managed patients went to the operating room 2.3
days after their initial joint aspiration (n=40). The average length of stay for surgicallymanaged patients was 19.8 days, as compared to 16.1 days for medically-managed
patients (p=0.53)
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All episodes of septic arthritis were initially treated with broad-spectrum
intravenous antibiotics, save the single case of fungal infection that was treated with oral
fluconazole. Following initial empiric therapy all patients were narrowed to
appropriately targeted antibiotics, when possible, based on culture results. Medicallymanaged patients received, on average, 37.6 total days of antibiotic therapy and 28.8 days
of intravenous antibiotics, less than the average of 54.0 days and 48.1 days respectively
for surgically-managed patients. These differences in duration of antibiotic therapy were
not, however, statistically significant (p=0.13, p =0.06).
Patient characteristics
The average age of our sample presenting with septic arthritis was 67.4 years old,
with no significant difference between the two treatment groups. 95% of patients were
male, consistent with the gender breakdown of the general population treated in the VA
system. 89% of patients were white, the rest black, with no significant difference
between the two treatment groups. In terms of risk factors for acquiring septic arthritis,
43% of the sample had diabetes mellitus (DM), 26% insulin-dependent DM, 11% had a
history of intravenous drug use (IVDU), 21% were on immunosuppressive
pharmacotherapy at the time of diagnosis of septic arthritis, and 43% had pre-existing
joint disease (RA, DJD, gout, etc.) of the infected joint. There was no significant
difference in the prevalence of any of these conditions between the medically- and
surgically-managed groups. Only 1 of 62 patients was HIV-positive, and only one had a
history of septic arthritis.
Table 1. Patient demographics, risk factors, and treatment details; overall and by type of mgmt
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Characteristics

Total
(n = 62)

Medical
(n = 19)

Surgical
(n = 43)

P-value

Age

67.4

66.4

67.9

0.72

Sex (male : female)

59:3

18:1

41:2

1.0

White

55 (89%)

17 (89%)

38 (88%)

1.0

Black

7 (11%)

2 (11%)

5 (12%)

1.0

Diabetes mellitus

27 (43%)

6 (32%)

22 (51%)

0.18

Insulin-dependent DM

16 (26%)

2 (11%)

14 (33%)

0.11

HIV

1 (1.6%)

1 (5.3%)

0 (0%)

0.31

IVDU

7 (11%)

2 (11%)

5 (12%)

1.0

Immunosuppressive meds

13 (21%)

5 (26%)

8 (19%)

0.51

Pre-existing joint disease

27 (43%)

7 (37%)

20 (47%)

0.58

Hx of septic arthritis

1 (1.6%)

1 (5.3%)

0 (0%)

0.31

Hx of surgery on joint

2 (3.2%)

1 (5.3%)

1 (2.3%)

1.0

# of joint aspirations
(not including OR)
Length of stay (days)

2.44

2.42

2.44

0.99

18.8

16.1

19.8

0.53

Total days of antibiotics

48.0

37.6

52.7

0.13

Days of IV Antibiotics

41.3

28.8

47.0

0.06

Race

Risk factors

Treatment

Pathogens and joints involved
Overall, 56% of patients had S. aureus isolated from cultures of joint fluid, joint
tissue, or blood. Of these, 32% were infected with MRSA. After Staphylococcus,
Streptococcus was the next most common isolated pathogen at 11% of the overall
sample. Gram-negative organisms were isolated in only 8% of patients. No organism
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was isolated in 6 patients (10%) who had recently been treated with antibiotics at the time
of diagnosis. There was no significant difference in the prevalence of organisms isolated
between patients managed medically versus surgically.
Table 2. Type of organism isolated; overall and by type of management
Organism

Total
(n = 62)
35 (56%)

Medical
(n = 19)
9 (47%)

Surgical
(n = 43)
26 (60%)

P-value

MSSA

24 (39%)

5 (26%)

19 (44%)

0.26

MRSA

11 (18%)

4 (21%)

7 (16%)

0.72

Coagulase-neg Staph

2 (3%)

1 (5%)

1 (2%)

1.0

Streptococcus

7 (11%)

2 (11%)

5 (12%)

1.0

Other Gram-positive

5 (8%)

3 (16%)

2 (5%)

0.31

Gram-negative

5 (8%)

2 (11%)

3 (7%)

0.98

No organism isolated

6 (10%)

2 (11%)

4 (9%)

1.0

S. aureus

0.41

In terms of joint location, knees were most commonly infected, accounting for
45% of the study sample. The shoulder was next most common at 23%, representing 11%
of medically-managed patients and 28% of surgically-managed ones. There were two
total hip infections, representing only 3% of the overall sample. There were four wrist
infections, all of which were treated medically, and four infections of the small joints of
the hands and feet which were all treated surgically. The only significant difference
between the two treatment groups was observed in wrist infections, which were
significantly over-represented in the medical group. As for involvement of multiple
joints, 16% of medically-managed patients presented with polyarthritis, similar to the rate
of 14% among surgically-managed patients.
Table 3. Location of infected joint; overall and by type of management
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Joint

Medical
(n = 19)
8 (42%)

Surgical
(n = 43)
20 (47%)

P-value

Knee

Total
(n = 62)
28 (45%)

Shoulder

14 (23%)

2 (11%)

12 (28%)

0.19

Ankle

5 (8%)

1 (5%)

4 (9%)

1.0

Small Joints

4 (6%)

-

4 (9%)

0.30

Wrist

4 (6%)

4 (21%)

-

0.01

Elbow

4 (6%)

3 (16%)

1 (2%)

0.08

Hip

2 (3%)

1 (5%)

1 (2%)

1.0

Sternoclavicular

1 (2%)

-

1 (2%)

1.0

0.79

Presentation and diagnosis
Based on chart review from their initial presentation, all 62 patients with septic
arthritis reported experiencing pain in the affected joint. 94% endorsed having limited
range of motion and 90% reported a history of swelling. On exam, 47% were found to
have erythema of the affected joint. Only 24% of presents were found to be febrile
(>37.0 C) at the time of presentation. In terms of factors potentially precipitating the
development of septic arthritis, no contributing factor could be identified in 55% of
patients. 18% reported a history of trauma to the joint, 10% reported a penetrating injury,
and 6% presented with infection adjacent to the joint in the form of cellulitis or
osteomyelitis.
Table 4. Prevalence of factors precipitating septic arthritis
Precipitating Factor
Number of
Patients (n = 62)
Adjacent infection
4 (6%)
Penetrating Injury
6 (10%)
Known Bacteremia
7 (11%)
Trauma
11 (18%)
Spontaneous (no factor identified)
34 (55%)
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Following Newman’s schema for the diagnosis of septic arthritis, 85% of patients
were diagnosed based on isolation of an organism from synovial fluid or, as in some of
cases managed surgically, from synovial tissue. An additional 5% of patients had an
organism cultured from the blood in the presence of symptoms suggestive of septic
arthritis. As mentioned above, in 6 patients (10%) no organism was ever isolated, though
all of these patients had recently been on antibiotic therapy and had purulent fluid
aspirated from the affected joint.
Table 5. Basis for diagnosis of septic arthritis
Source
Number of Patients
(n = 62)
Synovial fluid culture
48 (77%)
Synovial tissue culture
5 (8%)
Blood culture
3 (5%)
No organism isolated
5 (10%)

As for lab parameters collected at time of presentation, the overall average
synovial white blood cell count (WBC) was 114,427/mm3. The average synovial WBC
was slightly higher in the medically-managed group (126,437/mm3 vs. 109,966/mm3),
though this difference was not statistically significant (p=0.55). Synovial WBC was not
determined for 14 of the 62 patients, most commonly due to insufficient fluid collected
during aspiration. Of the 48 patients who did have a synovial WBC determined, 15% had
a synovial WBC less than 25,000/mm3 and an additional 15% had a synovial WBC
between 25,000/mm3 and 50,000/mm3. The average percentage of neutrophils within
the synovial WBC was 89.7%, with no significant difference between the two treatment
groups. The average serum WBC at presentation was 11.3 (+/ 5.5), also with no
significant difference between treatment groups. There was insufficient data for analysis
of baseline CRP values. The average baseline ESR among the medically-treated group
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was 59.4 (+/29.7), which was significantly lower than the average of 85.6 (+/22.5) among
the surgical group (p<0.01).
Table 6. Distribution of synovial WBC
Synovial WBC Range
Number of Patients
(count per mm3)
(n = 48)
< 25,000
7 (15%)
25,000 - 49,999
7 (15%)
50,000 - 99,999
11 (23%)
> 100,000
23 (48%)

Treatment outcomes
Overall, 7 of 62 patients died by the end of the 12-month follow-up period (11%),
4 of whom died prior to discharge (6.5%). Only 2 of the deaths, however, were
attributable to septic arthritis, corresponding to an overall mortality rate of 3.2% from
septic arthritis. The other two deaths that occurred prior to discharge were due to
respiratory failure secondary to aspiration pneumonitis and cardiac arrest. Both patients
who died from septic arthritis were managed surgically, resulting in a mortality rate of
4.7% for the surgically-managed group as compared to 0% for the medically-managed
group. This mortality difference is not, however, statistically significant (p=0.57).
Across the entire sample, 7 patients were excluded from the final 12-month
outcome analysis: two who were lost-to-follow-up (one from each treatment group), and
five who died from causes unrelated to septic arthritis before the follow-up period was
over. Of the remaining 55 patients with outcomes determined, 10 experienced a Poor
outcome: 3 in the medical group and 7 in the surgical group. As mentioned above, two of
these patients in the surgical group died from complications attributable to septic arthritis.
Three experienced significant deterioration in joint function as a result of their infection.
Three had recurrent septic arthritis of the same joint within one year, and one failed to
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clear the infection within one year. One additional patient had to have their finger
amputated as result of the infection.
Table 7. Patient outcomes at 1-year; overall and by type of management
Outcomes

Medical
(n = 19)
16 (84%)

Surgical
(n = 43)
39 (91%)

P-value

Outcome Determined

Total
(n = 62)
55 (89%)

Full Recovery

45 (73%)

13 (68%)

32 (74%)

0.76

Poor Outcome

10 (16%)

3 (16%)

7 (17%)

1.0

7 (11%)

3 (16%)

4 (9%)

0.67

Died during follow-up period

5 (8%)

2 (11%)

3 (7%)

0.98

Lost-to-follow-up

2 (3%)

1 (5%)

1 (2%)

1.0

No Outcome Determined

0.67

When considering only patients with an outcome determined (n=55), 13 of 16 medical
patients (81%) and 32 of 39 surgical patients (82%) had achieved full recovery in joint
function at one year from their diagnosis of septic arthritis. This small difference in
outcome was not statistically significant (p=1.0).
Univariate logistic regression showed no significant association between nearly
all of the analyzed variabless and having a Poor treatment outcome. No predisposing risk
factors or elements of the patient’s history conferred increased likelihood of failing to
achieve a full recovery. Neither the location of the affected joint nor the type of
causative organism were associated with greater likelihood of a Poor outcome. Nor were
any aspects of treatment, such as type of joint drainage, number of days to the operating
room, or duration of antibiotics significant in this analysis. The only factor that did
increase odds of a Poor outcome was being Black, which had an associated odds ratio of
9.5 (95% CI 1.3 -65.4).
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Table 8. Odds ratios for having a ‘Poor’ Outcome at 1-year
Variable
Odds Ratio
Surgical management

0.95

95% Confidence
Interval
0.2 - 4.2

Age > 65

0.70

0.1 - 2.8

Age > 80

1.16

0.2 - 6.5

White

1

Ref

Black

9.2

1.3 - 65.4

Race

Diabetes mellitus

*no ‘poor’ outcomes among
women; unable to do analysis
0.70
0.2 – 2.8

History of IVDU

4.4

0.8 – 24.0

History of joint disease

1.4

0.3 – 5.4

On immunosuppressive medications

3.1

0.7 – 13.5

Spontaneous

1

Ref

Trauma

2.1

0.4 – 10.8

Bacteremia

0.8

0.1 – 8.2

Penetrating injury

1.2

0.1 – 13.1

Adjacent infection

*no ‘poor’ outcomes; unable to do
analysis

Gender

Contributing factor

Joint location
Knee

1

Ref

Hip

3.80

0.2 – 72.0

Shoulder

0.69

0.1 - 4.2

Small Joints

1.90

0.1 - 25.5

Wrist

1.27

0.1 – 14.9

-

-

1

Ref

*No ‘poor’ outcomes among ankle, elbow, or
sternoclavicular joint infections
Organism
MSSA
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MRSA

0.67

0.1 – 4.1

Serum WBC

1.00

0.9 – 1.1

Serum ESR

1.00

0.97 - 1.03

Days to operating room

1.05

0.95 – 1.14

Total days of antibiotics

1.00

0.98 – 1.02

Days of IV antibiotics

1.00

0.98 – 1.02

In terms of discharge outcomes, 3 of 62 patients died prior to discharge and one
was referred to home hospice. Of the remaining 58 patients, 67% of medically-managed
patients were sent to a short-term rehabilitation facility or sent home with home physical
therapy services, as compared to 70% of surgically-managed patients requiring shortterm rehab or home physical therapy services (p=1.0).

V. Discussion
Prior to the discovery of modern antibiotics and their adoption in treating septic
arthritis, practitioners had little choice but to surgically drain purulent joints and hope for
the best. In current practice, even with administration of highly effective intravenous
antibiotic therapy, joint drainage remains an essential part of managing the infected joint
by helping to mitigate the destructive mechanisms of bacterial virulence, host immune
response, and tissue ischemia secondary to elevated intra-articular pressures. Although
rheumatologists and orthopedists have been draining infected joints surgically and via
closed-needle aspiration alongside antibiotic therapy for decades now, there is strikingly
little published data regarding which approach to joint drainage yields the best outcomes.
Our retrospective study of 62 cases of septic arthritis at the West Haven VA Medical
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Center has tried to help fill that gap by comparing treatment outcomes for patients
managed medically with antibiotics and close-needle aspiration against those managed
surgically with antibiotics and some form of surgical drainage.
Before discussing the outcomes observed, we should first comment briefly upon
the general presentation of septic arthritis among our unique study population at the VA
which was older, more predominantly male, and had a greater burden of chronic disease
(as measured by the percentage of patients with diabetes mellitus) than populations from
other similar studies. [3, 8, 34] First, the predominance of knee infections among our
population (45%) was in line with nearly all other studies of septic arthritis, which have
consistently identified the knee as the most commonly affected native joint. [1, 3, 7, 8]
The relative frequency of infections in other joints varies from study to study, and our
distribution was notable for a higher relative incidence of shoulder infections and lower
relative incidence of hip infections. Our findings on the relative frequency of causative
organisms was also consistent with broader literature identifying S. aureus as the most
common infectious agent in native joint septic arthritis, followed by Streptococcus
species. [36] The prevalence of MRSA within S. aureus joint infections (32%) was also
comparable to the rate found (41%) in another recent U.S. hospital study. [6]
Our study supports previous findings showing elevated average serum WBC,
serum ESR, and synovial WBC among those diagnosed with septic arthritis, although we
cannot comment regarding their relative specificity given our study design. It is
important to note, however, that, as found in prior studies, the sensitivity of synovial
WBC for diagnosing septic arthritis is very poor at lower levels. In our study, 30% of
patients diagnosed with septic arthritis would have been missed had a synovial WBC
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threshold of 50,000 cell per mm3 been used alone for diagnosis. Our study findings also
reinforce the observation from the review by Margaretten et al that the absence of fever
should not be considered at all when ruling out septic arthritis, as only 24% of our study
population was febrile at the time of presentation.
One notable difference between our study and the three others that have directly
compared medical versus surgical management of septic arthritis was our decision to also
include cases of septic arthritis without a positive synovial fluid or tissue culture, or socalled ‘culture-negative’ cases. 15% of our sample did not have a positive joint culture,
and prior studies have shown that nearly one-quarter of cases of septic arthritis will have
a negative synovial fluid culture. [37] Gupta et al in their comparison of cases of culturepositive versus culture-negative septic arthritis found that the two groups had similar
demographics, risk factors, and outcomes, suggesting the importance of treating culturenegative cases of septic arthritis no different from culture-positive ones. [27] Given the
prevalence of culture-negative septic arthritis and the similar outcomes observed, we see
our inclusion of culture-negative cases as a relative strength of our study design by
capturing the full spectrum of cases that practitioners must treat.
In terms of treatment outcomes, our overall mortality rate attributable to septic
arthritis of 3.2% is just below the low-end of the mortality range of 4-13% for native joint
infections documented in prior studies. [1-9] The lower rate may be partly due to
differences in attributing the cause of death, as we were particularly diligent in reviewing
all records of the 7 total patients who died during the study period in order to determine if
their death was related to joint infection. It is possible that prior studies were less strict in
their mortality attributions. Of course, the lower mortality rate may also simply represent
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normal variance to be expected across studies with such small sample sizes. As for
morbidity, our observed rate of ‘Full Recovery’ (82%) was greater than the rates
documented in the Ravindran (63%) and Goldenberg (71%) studies. [3, 8] This may be
attributable to the fact that our final outcome was determined a full 12-months after
diagnosis, while the outcomes for those studies were documented only at the time of
discharge and up to 3 months post-discharge, thus giving our study population more time
to recover and rehabilitate. We had relatively few patients where an outcome could not
be determined, and, as they were proportionally split between the two treatment groups,
are unlikely to have significantly affected our results.
In comparing outcomes between the two treatment groups, it is remarkable that
medically- and surgically-managed patients achieved ‘Full Recovery’ at near identical
rates (81% vs. 82%). While the mortality rate due to septic arthritis was higher among
the surgical group (4.7% vs 0%), with only 2 deaths in the entire sample it is hard to
attribute this difference to more than chance. Our findings are in slight contrast to the
prior studies mentioned which showed better outcomes with medical management,
though not at the level of statistical significance. [3, 8, 34] It is possible, as noted by
Goldenberg and Ravindran in their papers, that the disproportionate inclusion of hip
infections with notably poorer outcomes into their surgical treatment groups skewed their
results in favor of the medical groups. Both authors also point out though, that outcomes
were still better among their medical groups even when hip infections were excluded.
There are a few potential explanations for the improved outcomes among surgical
patients in our study as compared to prior studies. It is interesting to note that in our
study 69% of patients were treated surgically, while only 30% and 37% of patients in the
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Goldenberg and Ravindran studies underwent surgical joint drainage. It is possible that
surgeons within the VA CT medical system are more accustomed to draining septic
joints, which may contribute to their realizing better outcomes. It is perhaps more likely
that the relatively better outcomes among our surgical patients was due to the longer
follow-up period. It is quite possible that some of the surgically-managed patients in the
prior studies would have achieved full recovery had they been followed for 12 months
rather than for a few weeks or months at most. Given that the healthcare system should
generally be more focused on longer-term outcomes, we see our longer follow-up period
as a strength of this study contributing to the overall validity of our results.
It is important when comparing the outcomes of the medical and surgical
treatment groups in our study to highlight that there were no major differences of
statistical significance between the two groups. Our ingoing hypothesis was that surgical
management would be reserved for certain types of joint infections—based on either the
joint or organism involved—or for patients who were relatively ‘healthier’ and better
positioned to tolerate surgery. This appears, however, to not be the case. As shown in
Table 1, there were no significant differences in demographics or historical risk factors
between medically- and surgically-treated patients. In fact, surgically-treated patients
had higher rates of diabetes mellitus and pre-existing joint disease, suggesting that
surgery was not systematically reserved for ‘healthier’ patients. As for the impact of the
type of joint infected, there does appear to be some preference towards treating shoulders
and small joints surgically while generally avoiding surgery in elbow and wrist
infections. Only the difference in management of wrist infections, however, achieved
statistical significance. The type of organism involved also did not appear to affect
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clinical decision-making regarding drainage technique, though this may be less surprising
given that the determination to proceed with surgery must often be made before culture
results are available. The main point here is that while a majority of patients were treated
surgically, there were no measurably divergent variables when comparing the two groups
that would have undermined the validity of results through explicit selection bias.
Our study also had a few notable weaknesses that have generally plagued other
outcome studies of septic arthritis. First, it is obvious that the strength of our results
suffered from the small sample size inherent to studying a diagnosis as uncommon as
septic arthritis. Despite reviewing all records over 10 years from a large VA hospital, we
were only able to identify 62 cases of native joint septic arthritis. There are very few
studies of septic arthritis with sample sizes larger than 100. As a result, it was obviously
difficult to achieve statistical significance when comparing outcomes and risk factors
between two small treatment groups. It is quite possible that there were significant
differences between the two groups that our study was simply not powered to detect.
Perhaps the larger weakness of our study came in its retrospective, nonrandomized design. As a retrospective study, we had to rely on the quality of the existing
records in documenting often subjective or nuanced variables such as range of motion
and pain. Without a standard tool for prospective data collection, we were sometimes
unable to collect all of the data we would have liked for each individual case. For
example, there was large variation in provider documentation of key aspects of the
physical exam. The bigger issue with an observational study with two distinct treatment
groups is of course the problem of selection bias. While our groups do not appear
strikingly different based on the statistical analysis completed, it is impossible for us to
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know what factors affected the decision to pursue medical or surgical management for
each case. It is plausible that surgical intervention was used for cases that were deemed
to be ‘worst’ or ‘most aggressive’, while one might also argue that the surgical patients
had better underlying health based on factors not considered in our analysis. Without
prospective randomization, and particularly with a sample size, it is impossible to say that
our results were not affected by implicit or explicit selection bias.
To conclude, this study was designed to add to the limited body of evidence
regarding the relative superiority of closed-needle aspiration versus surgical drainage in
the management of septic arthritis. In that aim we have succeeded, by demonstrating
among our sample that medically- and surgically-managed patients achieved full
recovery at one year at near identical rates. Our results support prior findings that
medical management is, at a minimum, non-inferior to surgical joint drainage in
managing septic arthritis. Our study suffered, however, from the same problems of small
sample size and selection bias that limited the impact of previous studies. Unfortunately,
more than 40 years after Goldenberg’s seminal paper on this topic, his equivocal framing
of this issue still rings true: “The place of surgery in the treatment of septic arthritis is
debatable.” [3] It is clear that advancing our understanding of this topic—to the point of
providing a definitive recommendation in favor of medical or surgical management—will
require the design and execution of a randomized control trial. Given the low incidence
of septic arthritis, this would require coordination across multiple centers for several
years with involvement of the many specialties involved in the care of septic joints.
Ideally, this would be powered to enable analysis at the level of the joint, given the
differences in management by joint seen in prior studies. In the meantime, a meta-
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analysis consolidating the results of all the small retrospective studies to-date would
provide a valuable summation of our current understanding and may bolster our ability to
derive at least some provisional conclusions regarding the best way forward.
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